The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer

Journal of Urology

Volumn 164, Issue 3 I, 2000, Pages 735-737

  Chon, Joanna K ^a   Jacobs, Stephen C ^a   Naslund, Michael J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antineoplastic agents; Costs and cost analysis; Hormonal; Leuprolide; Prostate; Prostatic neoplasms

Indexed keywords

ANTIANDROGEN; GONADORELIN DERIVATIVE; LEUPRORELIN;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0033905178     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)67292-8     Document Type: Article

References (10)

1. Huggins, C. and Hodges, C. V.: Studies on prostatic cancer: effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res, 1: 293, 1941
2. Chodak, G. W.: Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma. Urology, suppl., 33: 42, 1989
3. Gamick, M. B.: Hormonal therapy in the management of prostate cancer: from Huggins to the present. Urology, suppl., 49; 5, 1997
4. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. Leuprolide Group N Engl J Med, 311: 1281, 1984
5. Crawford, E. D., Eisenberger, M. A., McLeod, D. G. et al: Comparison of bilateral orchiectomy with or without flutamide for the treatment of patients with stage D2 adenocarcinoma of the prostate: results of NCI intergroup study 0105 (SWOG and ECOG). J Urol, suppl., 157: 336, abstract 1311, 1996
6. Denis, L. J., Keuppens, F., Smith, P. H. et al: Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center. Eur Urol, 33: 144, 1998
7. Brealey, R. A. and Myers, S. C.: Principles of Corporate Finance, 3rd ed. New York: McGraw-Hill Publishing Co., chapt. 11, pp. 235-249, 1988
8. Crawford, E. D., Eisenberger, M. A., McLeod, D. G. et al: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med, 321: 419, 1989
9. Samdal, F., Vada, K., Lundmo, P. I. et al: Orchidectomy or LHRH-analogue? Which do the patients prefer and what treatment would Norwegian urologists prefer if they had advanced cancer of the prostate? Scand J Urol Nephrol, 25: 197, 1991
10. Merrill, D. C.: Treatment of metastatic prostate cancer. Factors that influence selection and methods to increase acceptance of orchiectomy. Urology, 32: 408, 1988